When will a corona vaccine come? Paul Ehrlich Institute gives an assessment that gives rise to hope

Researchers around the world are racing to get a vaccine against the coronavirus.

The health minister is concerned with who should be vaccinated first.

• All over the

  world

  is flat out on a

  vaccine

  against the coronavirus *

  researched.

• Nine

  candidates

  from international

  companies

  and

  research institutes

  are currently in the crucial

  test phase

  .

• Health Minister Jens Spahn also deals with

  the question of the distribution of

  vaccine

  doses

  against

  Covid-19 *

  (update from September 19, 8:17 a.m.).

Update from September 22, 2020, 7.31 a.m

.: Researchers around the world are feverishly looking for an effective

.

Nine vaccine candidates appear to be very promising.

To ensure the fair

, the

(WHO) called the

-Initative founded.

64 countries support Covax financially and thus secure access to the vaccine candidates, according to the WHO.

Germany *, Great Britain, France and many other European countries are among them.

A commitment from another 38 wealthy countries is expected in the next few days.

The USA and China are not there, although there are talks.

The Covax initiative aims to help 92 countries with low and middle incomes buy vaccine doses.

The WHO aims to deliver two billion doses of a vaccine by the end of 2021.

The prerequisite is that an efficient vaccine is found and approved by the authorities as quickly as possible.

She assumes that two vaccine doses per person are necessary.

Hope for corona vaccine

Update from September 19, 2020, 11:25 a.m.: It should be the

end of the year at the earliest: A

could be used and the

finally stopped.

The

expects

approval

for the

.

The

regularly represents

this assessment.

There are currently

in the final

, confirmed

the broadcasters

and

. 

Corona vaccine by the end of 2020?

RKI has to decide who gets the vaccine first

Nevertheless, there is still a long way to go.

Because if a

against the

approved, the Robert Koch Institute *

the big decision: Who will get the

first?

Also

feared: "I suppose a few more months to go in the next year into the country until we of

talk.

Globally, this can take most of the next year, if not all of next year ”.

Of course,

plays an important role.

Bringing the vaccine to market too quickly could be fatal.

“No compromises are made.” This is

another

reason why

likely to

be able to collect data

even during the

.

PEI President Prof. Klaus Cichutek today at the #Bundespressekonferenz: "The approval depends very much on the course of the phase III study. No compromises are made here in terms of safety, only a carefully tested #vaccine will be available to people. "

pic.twitter.com/8xVfOt0EyV

- Paul Ehrlich Institute (PEI) (@PEI_Germany) September 15, 2020

Internationally

, the

looks

worse: As

reports, a small group of countries (

) have already bought over half of the vaccines to be expected.

For many poorer countries *, the chances of

getting

a vaccine against the

are therefore

poor.

Vaccination against the corona virus: Federal Institute sees little headwind from the population

Of the

is expecting

, meanwhile,

little

.

Most are

more than positive about

a

.

"We can see that at the Paul Ehrlich Institute from the fact that at the beginning of the first clinical trials we had a lot of inquiries about

who would have liked to take part in the first clinical trials," confirms the President.

Update from September 19, 2020, 8:17 a.m.:

As soon as a

approved, the question will arise which people will be vaccinated first.

Because an immediate nationwide vaccination of the entire German population will not be possible immediately.

Therefore,

according to media reports,

Federal Health

wants

to regulate the distribution by the end of October.

Corona vaccine: who will get the first doses?

Doctors, ethics experts and social scientists should work out principles for this, as the newspapers of the

, citing government circles.

This advice is necessary because the distribution has not only a medical, but also an

.

+

Jens Spahn (CDU), Federal Minister of Health, speaks at a press conference after the video conference of the EU health ministers.

© Bernd von Jutrczenka / dpa

Spahn had advocated several times that

should be given a chance.

The federal government has announced that it will support the development of a corona vaccine by German companies with 750 million euros.

Worldwide there are currently

against the novel coronavirus in the third and final test phase.

In this phase, the drug is tested on thousands of people.

The corona situation is worsening again in France, Spain and Italy.

The number of new infections is particularly high.

Update from September 18, 2020, 2:03 p.m.:

The

has signed a contract to buy

a future

.

It is the second treaty that the EU has signed.

This time the manufacturers

and

are supposed to

deliver the vaccine.

Health Commissioner Stella Kyriakides said on Friday that in view of the rising number of corona infections, an effective vaccine is more important than ever.

The new treaty increases the chances that people in the EU and around the world will gradually be able to return to their everyday lives.

The

had already signed a contract with the manufacturer

.

More could follow.

However, none of the

has yet been approved.

The purchase agreements with advance payment are intended to accelerate the development and mass production of the vaccines.

The

has been in testing since September, with the crucial phase 3 study scheduled to follow by the end of 2020.

If everything goes smoothly, manufacturers want the vaccine available in the

, they say.

The

could also donate parts of the 300 million units to poorer countries.

Sanofi and GSK are also "eager"

to deliver

a significant portion of their

to the international Covax initiative.

This is intended to ensure that people worldwide have access to a future vaccine.

Corona vaccine: USA, China, Russia and Germany in a wild race - the overview

First report from September 16, 2020:

Berlin - Both in terms of

the rampant coronavirus * and the development of a

against

,

stands up

well in international comparison.

Despite the currently increasing number of cases, the currently falling R value gives hope *.

Nevertheless: A second wave could threaten here too *.

The

expects that there will be several different vaccines * in Germany.

But not only in

is currently working flat out on a vaccine against the novel coronavirus *.

The

from the international laboratories

not sleeping.

According to the WHO, a serum against

sought

in 176 projects worldwide

.

Nine of these potential

are currently

in the third and decisive test phase, in which the agent will be tested on tens of thousands of volunteers.

In some

, parts of the

even vaccinated,

according to their

.

Coronavirus vaccine - these candidates are in the third phase of testing:

USA: positive developments - vaccine against coronavirus in "three or four weeks"

"We are about to have a vaccine," said

on Tuesday evening on the US TV channel

.

More precisely, the

spoke

of "three or four weeks" in which one could have a

against the

.

and politicians in the

criticize the fact that the elections on November 3rd of this year would put political pressure on the US drug

.

“A vaccination has to be safe, effective and trustworthy,” Caitlin Rivers wrote in advance on Twitter.

The epidemiologist from the University of Johns Hopkins in Baltimore said that

the

must meet

all three criteria

: "It would be a tragedy if politicians, for political reasons, jeopardized the one thing that could allow us to ours return to normal life ”.

A vaccine must be safe, effective and trusted.

It's not a “pick 2” situation - we need all three.

It would be a tragedy if leaders jeopardized the thing that may allow us to safely return to our way of life for political expedience.

- Caitlin Rivers, PhD (@cmyeaton) August 22, 2020

The US pharmaceutical

, which is working together with the Mainz-based company

on a

against the

, was meanwhile able to

celebrate its

first successes in the third

.

As the

reports, the

now

that the number of participants in the tests could be increased from 30,000 to 44,000 subjects.

If the results are positive, Pfizer and Biontech could

apply for

approval of the

against the

as early as October

.

Russia: first approved vaccine against coronavirus - doubts about the veracity of the studies

+

Research is being carried out worldwide into a vaccine against the coronavirus.

© Ted S. Warren / dpa

Russia

was the first country in the world that had approved a vaccine against the coronavirus in an urgent manner and is

already

vaccinating parts of the

- despite international concerns.

The third

on the

and tolerability of

was not carried out prior to approval.

That caused a lot of criticism - experts even warned against the Russian vaccine against Covid-19.

As evidence of the effectiveness of

, the Russian

data on the

against the

in the specialist journal

at the beginning of September

.

However, some international

are

now questioning

the authenticity of these values ​​and suspecting

of

.

Upon closer inspection of the results, the experts

noticed

several

, as reported by the

*.

China: First vaccinations against the coronavirus - open to the public in a few months

China

is represented with many candidates in the international race for a

against the

, some of which are already

completing

the third

.

In this context, there has already been international criticism due to allegedly outrageous methods.

According to the government,

already being

vaccinated

against

with a potential

from the Institute of the People's Liberation Army

.

The development of a

against the

going "very smoothly", as an

the Center for

and Prevention

told

the Chinese TV broadcaster

on Monday evening.

According to her, the serum could be made available to the public "around November or December".

However

, the epidemiologist did not disclose

which of the many Chinese

it is.

Great Britain / Sweden: Third test phase of vaccine against coronavirus continues

AstraZeneca

is also

a bearer of hope in the search for a

against the

.

The Swedish-British pharmaceutical company recently suffered a major setback.

Last week, the

the third

had to be stopped - a test person is said to have contracted a rare neurological disease.

When the

, however, it was presumably a routine measure.

After a few days, the authorities confirmed that the disease was not due to the potential

against the

.

The study by AstraZeneca is therefore now being continued.

List of rubric lists: © Ted S. Warren / dpa